Developer docs
API playgroundTry for free, no card

Search company profiles

BioTexCom

Full company profile

uuid0024p2x

Namestring
BioTexCom
Websiteurl
biotexcom.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

BioTexCom is a Kyiv, Ukraine–based medical center that provides commercial surrogacy packages, mitochondrial replacement therapy, and egg donation services. Its client base is overwhelmingly cross-border: 95% of intended parents come from outside Ukraine, making it a medical-tourism operator targeting foreign intended parents whose home jurisdictions restrict or prohibit commercial surrogacy. Operationally, the company is positioned as a recognized participant in Ukraine's assisted-reproductive-treatment industry, which has made Ukraine the world's second-largest surrogacy hub globally.

The firm's revenue model is not publicly disclosed, nor are pricing details, contract structures, or unit economics available in the source data. Patient acquisition is implicitly driven by international referral networks, medical-tourism facilitators, and direct outreach to foreign intended parents, given the near-total dependence on inbound international demand. BioTexCom reports 1–10 employees, which almost certainly reflects only administrative or headquarters headcount rather than total clinical, medical, and surrogate-coordination personnel.

The company's strategic position is defined primarily by regulatory dependency. Ukraine's permissive legal environment for commercial surrogacy is the principal operational moat and simultaneously the principal existential risk: the Ukrainian parliament is considering a bill to ban foreigners from accessing commercial surrogacy and to tighten industry regulation, which — if enacted — would directly impair BioTexCom's revenue base given that 95% of clients are international. No founders, investors, parent entities, ownership structure, or AI/technology stack are disclosed in the available data.

Short descriptiontext

BioTexCom is a Kyiv-based medical center offering surrogacy packages, mitochondrial replacement therapy, and egg donation services to international intended parents, with 95% of clients coming from outside Ukraine.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKyiv, Ukraine
HQ citystring
Kyiv
HQ countrystring
Ukraine
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
surrogacy services, egg donation, mitochondrial replacement therapy, fertility treatment, medical tourism
Industry1 code
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
Product category
Fertility and Surrogacy Services
Social media profiles2 records
Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

BioTexCom is a Kyiv-based medical center that provides commercial surrogacy packages, mitochondrial replacement therapy, and egg donation services. Its offerings are aimed at international intended parents seeking fertility and family-building services in Ukraine's permissive commercial surrogacy market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 95% of intended parents are international clients from abroad
Product and service3 records
1Surrogacy Packages
CategorySurrogacy Services
Description

Comprehensive commercial surrogacy programs for international intended parents, including surrogate matching, medical procedures, and coordination of the journey in Ukraine. Aimed at couples or individuals whose home countries restrict or prohibit commercial surrogacy.

2Egg Donation Services
CategoryEgg Donation Services
Description

Egg donor matching and donation services for intended parents who need donor eggs as part of IVF or surrogacy treatment. Targets international intended parents seeking fertility assistance in Ukraine.

3Mitochondrial Replacement Therapy
CategoryAdvanced Fertility Treatment
Description

Advanced mitochondrial replacement therapy (a form of ART) offered as a medical service at the Kyiv clinic. Intended for intended parents seeking advanced fertility procedures that may be restricted or unavailable in their home countries.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

US-based surrogacy agency providing full-service programs for intended parents. Comparable to BioTexCom in core surrogacy service offering and package-based delivery model.

TypeDirect peer
Description

US surrogacy and egg donation agency serving a national and international client base. Comparable in service line and end-to-end intended-parent support model.

3ConceiveAbilities
TypeDirect peer
Description

US-based full-service surrogacy and egg donation agency. Comparable to BioTexCom in core offerings (surrogacy, egg donation) and full-stack case management for intended parents.

TypeBroad incumbent
Description

Global fertility clinic network offering IVF, egg donation, and reproductive medicine services across multiple geographies. Comparable as a broad incumbent in advanced reproductive services, even though it does not specialize in cross-border surrogacy case management like BioTexCom.

TypeDirect peer
Description

Ukraine-based surrogacy agency explicitly serving international intended parents. Directly comparable to BioTexCom on geography, regulatory environment, service mix, and customer base.

TypeDirect peer
Description

US-based surrogacy and egg donation agency with a long track record serving international intended parents. Comparable to BioTexCom in service scope (surrogacy + egg donation) and reliance on cross-border client acquisition.

TypeDirect peer
Description

Ukraine- and international-focused surrogacy agency serving foreign intended parents. Operates in the same regulatory and geopolitical environment as BioTexCom with the same cross-border demand model.

TypeDirect peer
Description

Established US-based surrogacy and egg donation agency serving intended parents, including international clients. Directly comparable to BioTexCom in core surrogacy service line, cross-border client handling, and end-to-end case management model.

TypeBroad incumbent
Description

Large US fertility clinic network offering IVF and broader assisted reproductive technology services. Comparable as a broader incumbent in the fertility/ART space into which BioTexCom's mitochondrial replacement and egg-donation services fit, though CCRM does not focus on surrogacy-only case management.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioTexCom

Fertility and Surrogacy Servicesbiotexcom.com

BioTexCom is a Kyiv-based medical center offering surrogacy packages, mitochondrial replacement therapy, and egg donation services to international intended parents, with 95% of clients coming from outside Ukraine.

What BioTexCom does

BioTexCom is a Kyiv, Ukraine–based medical center that provides commercial surrogacy packages, mitochondrial replacement therapy, and egg donation services. Its client base is overwhelmingly cross-border: 95% of intended parents come from outside Ukraine, making it a medical-tourism operator targeting foreign intended parents whose home jurisdictions restrict or prohibit commercial surrogacy. Operationally, the company is positioned as a recognized participant in Ukraine's assisted-reproductive-treatment industry, which has made Ukraine the world's second-largest surrogacy hub globally.

The firm's revenue model is not publicly disclosed, nor are pricing details, contract structures, or unit economics available in the source data. Patient acquisition is implicitly driven by international referral networks, medical-tourism facilitators, and direct outreach to foreign intended parents, given the near-total dependence on inbound international demand. BioTexCom reports 1–10 employees, which almost certainly reflects only administrative or headquarters headcount rather than total clinical, medical, and surrogate-coordination personnel.

The company's strategic position is defined primarily by regulatory dependency. Ukraine's permissive legal environment for commercial surrogacy is the principal operational moat and simultaneously the principal existential risk: the Ukrainian parliament is considering a bill to ban foreigners from accessing commercial surrogacy and to tighten industry regulation, which — if enacted — would directly impair BioTexCom's revenue base given that 95% of clients are international. No founders, investors, parent entities, ownership structure, or AI/technology stack are disclosed in the available data.

BioTexCom firmographics

Firmographics
Name
BioTexCom
Website
https://biotexcom.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
BioTexCom is a Kyiv-based medical center offering surrogacy packages, mitochondrial replacement therapy, and egg donation services to international intended parents, with 95% of clients coming from outside Ukraine.
Ownership category
akta.pro rank

BioTexCom industry classification

Industry
Product category
Fertility and Surrogacy Services
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

Keywords

  • Surrogacy services
  • Egg donation
  • Mitochondrial replacement therapy
  • Fertility treatment
  • Medical tourism

Where BioTexCom is headquartered

Location

Headquarters

HQ city
Kyiv
HQ country
Ukraine
HQ region
Europe

Markets served

BioTexCom business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

BioTexCom product offering

Product offering

Core offering

BioTexCom is a Kyiv-based medical center that provides commercial surrogacy packages, mitochondrial replacement therapy, and egg donation services. Its offerings are aimed at international intended parents seeking fertility and family-building services in Ukraine's permissive commercial surrogacy market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Surrogacy Packages Comprehensive commercial surrogacy programs for international intended parents, including surrogate matching, medical procedures, and coordination of the journey in Ukraine. Aimed at couples or individuals whose home countries restrict or prohibit commercial surrogacy.
  • Egg Donation Services Egg donor matching and donation services for intended parents who need donor eggs as part of IVF or surrogacy treatment. Targets international intended parents seeking fertility assistance in Ukraine.
  • Mitochondrial Replacement Therapy Advanced mitochondrial replacement therapy (a form of ART) offered as a medical service at the Kyiv clinic. Intended for intended parents seeking advanced fertility procedures that may be restricted or unavailable in their home countries.

Quantifiable outcome

  • 95% of intended parents are international clients from abroad

Companies that use BioTexCom

Customer profile

Segments1 record

Ideal customer profiles1 record

BioTexCom technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioTexCom partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

BioTexCom competitors and assessment

Company assessment

Direct peers

  • Simple Surrogacy: US-based surrogacy agency providing full-service programs for intended parents. Comparable to BioTexCom in core surrogacy service offering and package-based delivery model.
  • Family Source Consultants: US surrogacy and egg donation agency serving a national and international client base. Comparable in service line and end-to-end intended-parent support model.
  • ConceiveAbilities: US-based full-service surrogacy and egg donation agency. Comparable to BioTexCom in core offerings (surrogacy, egg donation) and full-stack case management for intended parents.
  • World Center of Baby: Ukraine-based surrogacy agency explicitly serving international intended parents. Directly comparable to BioTexCom on geography, regulatory environment, service mix, and customer base.
  • Growing Generations: US-based surrogacy and egg donation agency with a long track record serving international intended parents. Comparable to BioTexCom in service scope (surrogacy + egg donation) and reliance on cross-border client acquisition.
  • Delivering Dreams: Ukraine- and international-focused surrogacy agency serving foreign intended parents. Operates in the same regulatory and geopolitical environment as BioTexCom with the same cross-border demand model.
  • Circle Surrogacy: Established US-based surrogacy and egg donation agency serving intended parents, including international clients. Directly comparable to BioTexCom in core surrogacy service line, cross-border client handling, and end-to-end case management model.

Broad incumbents

  • IVI-RMA Global: Global fertility clinic network offering IVF, egg donation, and reproductive medicine services across multiple geographies. Comparable as a broad incumbent in advanced reproductive services, even though it does not specialize in cross-border surrogacy case management like BioTexCom.
  • CCRM Fertility: Large US fertility clinic network offering IVF and broader assisted reproductive technology services. Comparable as a broader incumbent in the fertility/ART space into which BioTexCom's mitochondrial replacement and egg-donation services fit, though CCRM does not focus on surrogacy-only case management.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights4 records

Customer concentration

BioTexCom social profiles

Digital presence

BioTexCom financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioTexCom leadership team

Management profile

Number of profiles

BioTexCom funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioTexCom M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioTexCom

What does BioTexCom do?

BioTexCom is a Kyiv-based medical center that provides commercial surrogacy packages, mitochondrial replacement therapy, and egg donation services. Its offerings are aimed at international intended parents seeking fertility and family-building services in Ukraine's permissive commercial surrogacy market.

Is BioTexCom a public or private company?

BioTexCom is a private company. It is classified as unknown and is currently operating.

When was BioTexCom founded?

BioTexCom was founded in -1. It employs 1 to 10 people.

Where is BioTexCom based?

BioTexCom is headquartered in Kyiv, Ukraine, in the Europe region.

Who are BioTexCom's main competitors?

Direct peers on record are Simple Surrogacy, Family Source Consultants, ConceiveAbilities, World Center of Baby, Growing Generations, Delivering Dreams and Circle Surrogacy. Broad incumbents are IVI-RMA Global and CCRM Fertility.

Does BioTexCom have an API?

No public API is recorded for BioTexCom.

What industry is BioTexCom in?

BioTexCom's product category is Fertility and Surrogacy Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ThegrayzoneUkraine’s baby factories rake in record profits amid chaos of warUkraine's surrogacy industry, led by BioTexCom, has become a major profit center amid war, with the company controlling 25% of the global market. The industry pumped over $1.5 billion into Ukraine's economy in 2018, and the global market is projected to grow 25% annually. Advocates call for international regulation to protect vulnerable women.The Guardian‘The bombs won’t stop us’: business brisk at Ukraine’s surrogacy clinicsUkraine's surrogacy clinics continue brisk business during the war, with over 1,000 children born to surrogate mothers since the invasion began. BiotexCom clinic in Kyiv has handled 600 births, and foreign couples still travel despite air raids. The industry faces criticism and a proposed ban on foreign surrogacy during martial law.POLITICOInside a Ukrainian baby factoryAn investigation into Ukraine's BioTexCom surrogacy agency uncovered client complaints, including misplaced embryos and health issues for surrogates. The founder denied allegations, citing poor embryo quality and hospital errors. The company continues operations amid the war, with surrogacy packages costing $40,000 to $50,000.The New York Times100 Babies Stranded in Ukraine After Surrogate BirthsDozens of babies born to surrogate mothers in Ukraine are stranded because their foreign parents cannot enter due to travel bans. At least 100 are already marooned, with up to 1,000 expected before restrictions lift. BioTexCom, the largest surrogate provider, says it will do all it can to reunite them.NPRSurrogate-Born Babies Wait In Ukraine Amid Coronavirus Travel RestrictionsCoronavirus travel restrictions have left surrogate-born babies in Ukraine waiting for parents to collect them. BioTexCom's video showed dozens of infants, and about 100 babies are pending pickup, with numbers potentially rising to thousands if restrictions extend. Ukraine's surrogacy industry, estimated at 2,000-2,500 births annually, has been halted by the foreigner ban.Business Insider51 Ukrainian babies born to surrogate mothers are stranded at a hotel in Kiev because their adoptive parents can't cross the borderNearly 100 surrogate-born babies are stranded in Ukraine because their adoptive parents cannot cross the border due to coronavirus restrictions. BioTexCom is caring for 51 newborns, with 15 more with parents who entered before the shutdown. Ukraine's ombudswoman seeks a mechanism to resolve the situation, which remains unresolved.ReutersUkrainian surrogate babies bound for U.S., Europe stranded by virus lockdownAt least 51 babies born to surrogate mothers are stranded in a Kiev clinic as coronavirus lockdown prevents foreign parents from collecting them. The clinic, BioTexCom, released video footage to pressure the government, and the human rights ombudsman ordered checks, finding procedures followed.ABCInside Ukraine's surrogacy industry where Australians are travelling to have a familyUkraine's liberal surrogacy laws attract foreign couples, with costs of 30,000-40,000 euros for donor-egg surrogacy. Agencies like Biotexcom handle 150 applications monthly, and Australian children born via Ukrainian surrogates tripled from nine in 2017 to 26 in 2018. Ukrainian MPs are debating bills to restrict foreign surrogacy.